HOUSTON – Targeted cancer therapy pioneer John Mendelsohn, M.D., researcher and former president of The University of Texas MD Anderson Cancer Center, will share the 2018 Tang Prize in Biopharmaceutical Science for his leadership in developing antibodies to block cancer-promoting growth factor receptors on the surface of cancer cells. In announcing the award on June 19 in Taiwan, the Tang Foundation noted the three awardees launched the field of targeted therapy – attacking tumors based on their genetic and molecular […]
